Mumbai-based pharmaceutical company Piramal Healthcare today reported a 45 per cent increase in its net profit for the first quarter ended June 30, 2009 at Rs 74.11 crore as compared to Rs 50.94 crore recorded for the corresponding quarter a year ago.
Income from operations for the same period increased by 16 per cent to Rs 569.73 crore as against Rs 498.12 crore posted in the same quarter in the earlier year.
Consolidated net profit for the same period rose by 25 per cent at Rs 85.10 crore as compared to Rs 68.09 crore while consolidated net income from operations grew by 16 per cent at Rs 821.54 crore as against Rs 708.32 crore.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app